- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration +12009 | Faculty of Medicine in Hradec Králové
- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration2009 | First Faculty of Medicine
- Ranibizumab for the treatment of choroidal neovascularization due to cause other than age related macular degeneration2019 | Faculty of Medicine in Hradec Králové